close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

527.40 +26.18 (+5.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
1 Volatile Stock Worth Investigating and 2 That Underwhelm
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Medpace and Revvity Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
3 Market-Beating Stocks with Competitive Advantages
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Kohl’s, Medpace, General Motors, Lockheed Martin, Northrop Grumman: Stocks Making The Biggest Moves Today
Via Stocktwits
This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
 
Via Benzinga
Why Medpace (MEDP) Stock Is Trading Lower Today
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.2% in the morning session after Barclays downgraded the stock to "Underweight" from "Equal-Weight" and reduced its price... 
Via StockStory
Breaking Down Medpace Hldgs: 10 Analysts Share Their Views
 
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025
From Medpace Holdings, Inc.
Via Business Wire
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Regulatory Compliance
Medpace Hldgs Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
 
Via Benzinga
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
2 Mooning Stocks to Target This Week and 1 That Underwhelm
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
2 Reasons to Watch MEDP and 1 to Stay Cautious
Medpace currently trades at $450.01 and has been a dream stock for shareholders. It’s returned 266% since August 2020, more than tripling the S&P 500’s 85.3% gain. The company has also beaten the index... 
Via StockStory
Topics Stocks Supply Chain
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
Why Medpace (MEDP) Stock Is Trading Lower Today
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.3% in the morning session after UBS downgraded the stock to 'Sell' from 'Neutral', sending shares lower. The investment bank... 
Via StockStory
Uber To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
Stocks making big moves this week: Cal-Maine, Skillz, TransUnion, Medpace, and Bruker
Check out the companies making headlines this week: 
Via StockStory
Medpace (MEDP) Stock Trades Down, Here Is Why
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 7.5% in the afternoon session after an analyst at TD Cowen downgraded the stock to "Sell" from "Hold," citing valuation concerns... 
Via StockStory
This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta
Check out the companies making headlines yesterday: 
Via StockStory
Demystifying Medpace Hldgs: Insights From 4 Analyst Reviews
 
Via Benzinga
Medpace Beats Q2 Revenue Estimates
Via The Motley Fool
Which stocks are experiencing notable movement on Tuesday?
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
MEDP Q2 Deep Dive: Backlog Conversion, Lower Cancellations, and Therapeutic Mix Drive Outlook
Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q2 CY2025, with sales up 14.2% year on year to $603.3 million. The company’s full-year revenue... 
Via StockStory
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?
It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today